Target intelligence / Profile preview

Synapse-associated protein 1 (SYAP1)

Target
SYAP1
Molecular classification
Other (specifically: BSD domain-containing adaptor/scaffold protein, not a receptor, enzyme, GPCR, or typical transporter)
01

Overview

Synapse-associated protein 1 (SYAP1) is a BSD domain-containing adaptor protein that interacts with signaling partners such as Akt1, promoting phosphorylation of Akt1 at Ser477 in a process facilitated by mTORC2, and is involved in cellular response to growth factors including epidermal growth factor and peptide hormones[1][3]. This phosphorylation event is implicated in adipocyte differentiation by suppressing FoxC2 expression[1]. In mammals, SYAP1’s most prominent expression is within the nervous system, particularly in cerebellar Purkinje cells and cerebellar nuclei, as well as throughout regions rich in glutamatergic synapses[2]. Knockout mouse studies show that loss of SYAP1 results in distinct locomotor and motor adaptation defects, but does not affect basic metabolic parameters, cognition, or general viability. The gene is located on Xp22.2, a locus associated with neurodevelopmental disorders, with mutations in humans linked to developmental delay and autism spectrum[2][3]. Functionally, SYAP1 is not a receptor, enzyme, transporter, or classic drug target, but serves as a scaffold/adaptor implicated in signaling and neuronal function[1][2][3].

Other names
BSTAPRO3113FLJ14495BSD domain-containing signal transducer and Akt interactor proteinSAP47 homolog (Drosophila)SAP47 homologsynapse associated protein 1
02

Biological functions

Signal transduction (TORC2/mTORC2 signaling)Cellular response to growth factors (epidermal growth factor, peptide hormone stimulus)Adipocyte differentiation (through Akt1 phosphorylation)Synaptic function/modulation (especially in nervous system, cerebellum)Potential role in vesicular trafficking
03

Disease associations

Neurodevelopmental disorders (evidence for involvement in loci associated with mental retardation, developmental delay, autism spectrum disorder)Motor disorders (SYAP1 knockout associated with impaired motor behavior in mice)Other (Pettigrew syndrome and Autosomal Recessive Robinow Syndrome by locus association, not direct causality)

Beyond the preview

Go deeper on Synapse-associated protein 1 (SYAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synapse-associated protein 1 (SYAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call